Literature DB >> 27001282

Opuntia ficus-indica seed attenuates hepatic steatosis and promotes M2 macrophage polarization in high-fat diet-fed mice.

Jung-Woo Kang1, Jun-Kyu Shin1, Eun-Ji Koh2, Hyojeong Ryu2, Hyoung Ja Kim3, Sun-Mee Lee4.   

Abstract

Opuntia ficus-indica (L.) is a popular edible plant that possesses considerable nutritional value and exhibits diverse biological actions including anti-inflammatory and antidiabetic activities. In this study, we hypothesized that DWJ504, an extract of O ficus-indica seed, would ameliorate hepatic steatosis and inflammation by regulating hepatic de novo lipogenesis and macrophage polarization against experimental nonalcoholic steatohepatitis. Mice were fed a normal diet or a high-fat diet (HFD) for 10 weeks. DWJ504 (250, 500, and 1000 mg/kg) or vehicle (0.5% carboxymethyl cellulose) were orally administered for the last 4 weeks of the 10-week HFD feeding period. DWJ504 treatment remarkably attenuated HFD-induced increases in hepatic lipid content and hepatocellular damage. DWJ504 attenuated increases in sterol regulatory element-binding protein 1 and carbohydrate-responsive element-binding protein expression and a decrease in carnitine palmitoyltransferase 1A. Although DWJ504 augmented peroxisome proliferator-activated receptor α protein expression, it attenuated peroxisome proliferator-activated receptor γ expression. Moreover, DWJ504 promoted hepatic M2 macrophage polarization as indicated by attenuation of the M1 marker genes and enhancement of M2 marker genes. Finally, DWJ504 attenuated expression of toll-like receptor 4, nuclear factor κB, tumor necrosis factor α, interleukin 6, TIR-domain-containing adapter-inducing interferon β, and interferon β levels. Our results demonstrate that DWJ504 prevented intrahepatic lipid accumulation, induced M2 macrophage polarization, and suppressed the toll-like receptor 4-mediated inflammatory signaling pathway. Thus, DWJ504 has therapeutic potential in the prevention of nonalcoholic fatty liver disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  High-fat diet fed mice; Lipid accumulation; Macrophage polarization; Non-alcoholic fatty liver disease; Opuntia ficus-indica seed; Toll-like receptor 4

Mesh:

Substances:

Year:  2015        PMID: 27001282     DOI: 10.1016/j.nutres.2015.12.007

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  5 in total

1.  Scopolin ameliorates high-fat diet induced hepatic steatosis in mice: potential involvement of SIRT1-mediated signaling cascades in the liver.

Authors:  Ahyoung Yoo; Vikram P Narayan; Eun Young Hong; Wan Kyunn Whang; Taesun Park
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

Review 2.  The Potential Therapeutic Value of Medicinal Plants in the Management of Metabolic Disorders.

Authors:  Trevor T Nyakudya; Thulani Tshabalala; Rachael Dangarembizi; Kennedy H Erlwanger; Ashwell R Ndhlala
Journal:  Molecules       Date:  2020-06-09       Impact factor: 4.411

Review 3.  Macrophage Polarization and Its Role in Liver Disease.

Authors:  Cheng Wang; Cheng Ma; Lihong Gong; Yuqin Guo; Ke Fu; Yafang Zhang; Honglin Zhou; Yunxia Li
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

4.  Protective Effect of Nopal Cactus (Opuntia ficus-indica) Seed Oil against Short-Term Lipopolysaccharides-Induced Inflammation and Peroxisomal Functions Dysregulation in Mouse Brain and Liver.

Authors:  Mounia Tahri-Joutey; Fatima-Ezzahra Saih; Riad El Kebbaj; Catherine Gondcaille; Joseph Vamecq; Norbert Latruffe; Gérard Lizard; Stéphane Savary; Boubker Nasser; Mustapha Cherkaoui-Malki; Pierre Andreoletti
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

5.  Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease.

Authors:  Linqiang Zhang; Xiaoyun Wu; Shasha Liao; Yunhai Li; Zhiguo Zhang; Qing Chang; Ruyue Xiao; Bin Liang
Journal:  Biol Open       Date:  2016-10-15       Impact factor: 2.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.